Evidence map›Paper›PMID 25595442›Full record

ArticleClinical and experimental nephrology2015

End-stage renal disease in Japanese children: a nationwide survey during 2006-2011.

Motoshi Hattori, Mayumi Sako, Tetsuji Kaneko, Akira Ashida, Akira Matsunaga, Tohru Igarashi, Noritomo Itami, Toshiyuki Ohta, Yoshimitsu Gotoh, Kenichi Satomura and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Motoshi HattoriDepartment of Pediatric Nephrology, School of Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. hattori@kc.twmu.ac.jp.
Mayumi SakoDivision for Clinical Trials, Department of Development Strategy, Center for Social and Clinical Research, National Center for Child Health and Development, Tokyo, Japan.
Tetsuji KanekoDivision of Clinical Research Support Center, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Akira AshidaDepartment of Pediatrics, Osaka Medical College, Osaka, Japan.
Akira MatsunagaMatsunaga Kids Clinic, Yamagata, Japan.
Tohru IgarashiDepartment of Pediatrics, Nippon Medical University, Tokyo, Japan.
Noritomo ItamiKidney Center, Nikko Memorial Hospital, Hokkaido, Japan.
Toshiyuki OhtaDepartment of Pediatric Nephrology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Yoshimitsu GotohDepartment of Pediatrics, Nagoya Daini Red Cross Hospital, Aichi, Japan.
Kenichi SatomuraDepartment of Pediatric Nephrology and Metabolism, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
Masataka HondaDepartment of Nephrology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Takashi IgarashiNational Center for Child Health and Development, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnd-stage renal disease (ESRD) in children is considered a rare, but serious condition. Epidemiological and demographic information on pediatric ESRD patients around the world is important to better understand this disease and to improve patient care. The Japanese Society for Pediatric Nephrology (JSPN) reported epidemiological and demographic data in 1998. Since then, however, there has been no nationwide survey on Japanese children with ESRD.

methodsThe JSPN conducted a cross-sectional nationwide survey in 2012 to update information on the incidence, primary renal disease, initial treatment modalities, and survival in pediatric Japanese patients with ESRD aged less than 20 years during the period 2006-2011.

resultsThe average incidence of ESRD was 4.0 per million age-related population. Congenital anomalies of the kidney and urinary tract were the most common cause of ESRD, present in 39.8 % of these patients. In addition, 12.2 % had focal segmental glomerulosclerosis and 5.9 % had glomerulonephritis. Initial treatment modalities in patients who commenced renal replacement therapy (RRT) consisted of peritoneal dialysis, hemodialysis, and pre-emptive transplantation (Tx) in 61.7, 16.0, and 22.3 %, respectively. The Japanese RRT mortality rate was 18.2 deaths per 1000 person-years of observation.

conclusionThe incidence of ESRD is lower in Japanese children than in children of other high-income countries. Since 1998, notably, there has been a marked increase in pre-emptive Tx as an initial treatment modality for Japanese children with ESRD.

Indexed as

AdolescentAsian PeopleCause of DeathChildChild, PreschoolCross-Sectional StudiesFemaleGlomerulosclerosis, Focal SegmentalHealth SurveysHumansIncidenceInfantInfant, NewbornJapanKidneyKidney Failure, ChronicChildrenEnd-stage renal diseaseEpidemiologyJapanRenal replacement therapy

Identifiers

PMID25595442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.